Head to Head Analysis: Bullfrog AI (NASDAQ:BFRG) versus Stevanato Group (NYSE:STVN)

Stevanato Group (NYSE:STVNGet Free Report) and Bullfrog AI (NASDAQ:BFRGGet Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, earnings and profitability.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Stevanato Group and Bullfrog AI, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group 0 2 2 2 3.00
Bullfrog AI 1 1 0 0 1.50

Volatility & Risk

Stevanato Group has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Comparatively, Bullfrog AI has a beta of -2.7, indicating that its share price is 370% less volatile than the S&P 500.

Earnings & Valuation

This table compares Stevanato Group and Bullfrog AI”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Stevanato Group $1.23 billion 5.43 $158.21 million €0.56 39.20
Bullfrog AI $120,000.00 88.10 -$6.50 million ($0.46) -1.24

Stevanato Group has higher revenue and earnings than Bullfrog AI. Bullfrog AI is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

1.0% of Bullfrog AI shares are owned by institutional investors. 0.7% of Stevanato Group shares are owned by company insiders. Comparatively, 14.7% of Bullfrog AI shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Stevanato Group and Bullfrog AI’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Stevanato Group 10.99% 10.43% 6.16%
Bullfrog AI N/A -150.36% -127.98%

Summary

Stevanato Group beats Bullfrog AI on 11 of the 14 factors compared between the two stocks.

About Stevanato Group

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

About Bullfrog AI

(Get Free Report)

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.